International differential pricing: easy in theory but hard in practice

Authors

  • Bruce CM Wang Alliance Life Sciences, Jersey City, NJ, USA
  • Mohan Purushothaman Alliance Life Sciences, Jersey City, NJ, USA

DOI:

https://doi.org/10.7175/fe.v14i3.648

Keywords:

Health Technology Assessment (HTA), Pharmaceutical pricing scheme, Patented medicines

References

Tsang K, Wang B, Patel P. Do Macroeconomic Conditions Explain Drug Price Variations Across Countries? A Cross-Sectional Analysis. International Society for Pharmacoeconomics and Outcomes Research Asia-Pacific Meeting, Taipei, Taiwan 2012

Danzon P, Towse A, Mestre-Ferrandiz J. Value-based differential pricing: efficient prices for drugs in a global context. National Bureau of Economic Research Working Paper No. 18593. Available at http://www.nber.org/papers/w18593 (Last accessed February 2013).

Danzon P, Towse A. Differential pricing for pharmaceuticals: reconciling access, R&D and patents. Int J Health Care Finance Econ 2003; 3: 183-205

World Development Indicators database, World Bank. Database updated on 21 December 2012. Accessed on 30 December 2012

Veblen, Thorstein. The Theory of the Leisure Class. Introduction John Kenneth Galbraith. Boston: Houghton Mifflin, 1973

Downloads

Published

2013-09-10

Issue

Section

Editorial

How to Cite

International differential pricing: easy in theory but hard in practice. (2013). Farmeconomia. Health Economics and Therapeutic Pathways, 14(3), 107-109. https://doi.org/10.7175/fe.v14i3.648